Treatment of Uncontrolled Diabetes with Ketosis and Ketonuria 2+

Clinical Context

Step 1 — Severity Classification (ADA Criteria)

Ketonuria 2+ indicates significant ketonemia. β-hydroxybutyrate >3.0 mmol/L confirms DKA; note that nitroprusside-based urine strips detect only acetoacetate/acetone, not β-hydroxybutyrate — so ketonuria may underestimate true severity.

Step 2 — Treatment Algorithm

Four Pillars of Treatment

1. 🧪 Fluid Replacement (Most Urgent)

• Fluid losses of 5–10 liters are typical in DKA (Goldman-Cecil Medicine)
• Initial: 0.9% Normal Saline (NS) — 1 L bolus, then 2–4 liters over the first 2–4 hours
  • 0.9% NS is used even if osmolality is high because it is relatively hypotonic to plasma
  • Continue 0.9% NS at ~200 mL/hr, alternating with 0.45% NS as sodium normalizes
• Once glucose falls to <250 mg/dL: Add 10% dextrose alongside the NS to provide substrate for continued insulin infusion and prevent hypoglycemia while ketones clear
• Caution: Slow fluid replacement in patients with ischemic heart disease, heart failure, or renal impairment

2. 💉 Insulin

• Fixed-rate IV insulin infusion: 0.1 units/kg/hour
• Monitor blood glucose hourly (FSBS q1h)
• Once glucose <250 mg/dL AND ketones <1.0 mmol/L → reduce to 0.05 units/kg/hour to prevent hypoglycemia and hypokalemia
• Continue until patient can eat, then overlap with subcutaneous insulin by 1–2 hours before stopping IV infusion (to avoid rebound ketosis)

• 0.3 units/kg rapid-acting insulin (e.g., lispro or aspart)
• Check FSBS every 2 hours; target <200 mg/dL
• Subcutaneous regimens are also effective per Goodman & Gilman

If the patient was already on background long-acting subcutaneous insulin, continue it alongside the IV infusion.

3. 🧂 Potassium Replacement

4. 🫧 Bicarbonate

• Routinely NOT recommended — risk of paradoxically worsening CNS pH and cerebral edema
• Restoration of volume and insulin therapy usually corrects acidosis
• Only consider if: pH <7.0 AND not responding to fluids/insulin
  • Give 100 mmol NaHCO₃ in 400 mL water with 20 mEq KCl over 2 hours
  • Aim to raise pH above 7.1 only; do not attempt to normalize pH

Step 3 — Identify and Treat the Precipitant

• Infection (most common) — CBC, cultures, CXR, urinalysis
• Insulin omission or pump failure
• New-onset Type 1 DM
• Myocardial infarction, pancreatitis, medications (steroids, SGLT2 inhibitors)

The white blood cell count is typically elevated even without infection due to metabolic acidosis itself — do not diagnose infection on WBC alone.

Step 4 — Monitoring During Treatment

Note: Urine ketones may appear to worsen after insulin is started (as β-OHB converts to acetoacetate). Use blood ketones or anion gap as the primary marker of resolution, not urine ketones.

Resolution Criteria (DKA)

• Blood glucose <250 mg/dL
• Serum bicarbonate ≥15 mmol/L
• Venous pH >7.30
• Blood β-OHB <1.0 mmol/L (where available)

Phosphate & Magnesium

• Measure and monitor
• Routine IV replacement is not recommended unless phosphate <1.0 mg/dL with profound muscle weakness

Transition to Outpatient Therapy (after resolution)

• Resume usual diabetes regimen
• Sick-day rules education: frequent glucose monitoring, ketone testing when unwell, small frequent carbohydrate-containing fluids, adjust insulin rather than stop it
• Address compliance, device issues, or diabetes education gaps

Recent Evidence Update

• Subcutaneous vs IV insulin (PMID 39090718): Subcutaneous insulin is comparable to continuous IV infusion in adult DKA management
• Balanced electrolyte solutions vs 0.9% NS (PMID 38925619): Balanced solutions (e.g., Lactated Ringer's, PlasmaLyte) result in faster DKA resolution than normal saline
• Early basal insulin with IV infusion (PMID 41208563): Giving subcutaneous basal insulin early alongside IV infusion reduces rebound ketosis after IV discontinuation

These findings suggest that subcutaneous protocols are a valid alternative for mild-moderate DKA, and balanced crystalloids may be preferred over 0.9% NS when available.